Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria gonorrhoeae outer membrane vesicle (OMV) antigens are components of small, spherical vesicles (~50 nm in diameter) naturally released from the outer membrane of N. gonorrhoeae. These OMVs contain a variety of surface-exposed proteins and other molecules derived from the bacterial outer membrane, including key antigens such as PorB, Opa proteins, PilQ, and NHBA. They play roles in pathogenesis by delivering virulence factors, modulating host immune responses, and evading innate immunity. Several surface-exposed antigens within N. gonorrhoeae OMVs are recognized by antibodies generated against related Neisseria species, supporting cross-protection between species. The presence of conserved surface-exposed antigens makes N. gonorrhoeae OMV components attractive vaccine targets.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria gonorrhoeae Outer Membrane Vesicle Antigen (NG OMV Antigen).